The clinical efficacy of artemether/lumefantrine (Coartem®)
Open accessThe DOI matches its Crossref record.
Abstract
Current World Health Organization (WHO) guidelines for the treatment of uncomplicated falciparum malaria recommend the use of artemisinin-based combination therapy (ACT). Artemether/lumefantrine is an ACT prequalified by the WHO for efficacy, safety and quality, approved by Swissmedic in December 2008 and recently approved by the USA FDA. Coartem is a fixed-dose combination of artemether and lumefantrine. Its two components have different modes of action that provide synergistic anti-malarial activity. It is indicated for the treatment of infants, children and adults with acute, uncomplicated infection due to Plasmodium falciparum or mixed infections including P. falciparum. A formulation with improved palatability has been developed especially for children (Coartem Dispersible), which rapidly disperses in a small amount of water for ease of administration. The efficacy of the six-dose regimen of artemether/lumefantrine has been confirmed in many different patient populations around the world, consistently achieving 28-day PCR (polymerase chain reaction)-corrected cure rates of >95% in the evaluable population, rapidly clearing parasitaemia and fever, and demonstrating a significant gametocidal effect, even in areas of widespread parasite resistance to other antimalarials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Venkatesan, M., Gadalla, N. B., Stepniewska, K., Dahal, P., Nsanzabana, C., Moriera, C., Price, R. N., Mårtensson, A., Rosenthal, P. J., Dorsey, G., et al. (2014) · The American Society of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.14-0031 · Cited by 285
Efferth, T., & Oesch, F. (2021) · Medicinal Research Reviews · doi:10.1002/med.21842 · Cited by 218
Wind direction and proximity to larval sites determines malaria risk in Kilifi District in Kenya
Midega, J. T., Smith, D. L., Olotu, A., Mwangangi, J. M., Nzovu, J. G., Wambua, J., Nyangweso, G., Mbogo, C. M., Christophides, G. K., Marsh, K., et al. (2012) · Nature Communications · doi:10.1038/ncomms1672 · Cited by 97
Manyando, C., Kayentao, K., D’Alessandro, U., Okafor, H. U., Juma, E., & Hamed, K. (2012) · Malaria Journal · doi:10.1186/1475-2875-11-141 · Cited by 62
“The efficacy of AL during pregnancy in the two Ugandan trials, but not the Thai trial, is similar to the results from studies in adults and children that have consistently reported AL efficacy of over 95% [44].”
ResultAbdulla, S., Amuri, B., Kabanywanyi, A. M., Ubben, D., Reynolds, C., Pascoe, S., Fitoussi, S., Yeh, C.-M., Nuortti, M., Séchaud, R., et al. (2010) · Malaria Journal · doi:10.1186/1475-2875-9-253 · Cited by 34
“This tablet formulation, containing 20 mg of artemether and 120 mg of lumefantrine, has been proven to be efficacious and safe in the treatment of uncomplicated Plasmodium falciparum malaria when administered in a six-dose regimen for 3 days [7,8].”
Method
Metadata
- Authors
- Makanga, M., & Krudsood, S.
- Venue
- Malaria Journal
- Published
- 2009-10-12
- Volume
- 8
- Issue
- S1
- Pages
- S5-S5
- ISSN
- 1475-2875 (ISSN-L)
- OpenAlex
- W2023948728
- Cited by
- 109
- References
- 0
- FWCI
- 8.95
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The clinical efficacy of artemether/lumefantrine (Coartem®). https://app.cochat.ai/papers/10.1186/1475-2875-8-s1-s5
- The paper
- Makanga, M., & Krudsood, S. (2009). The clinical efficacy of artemether/lumefantrine (Coartem®). Malaria Journal. https://doi.org/10.1186/1475-2875-8-s1-s5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.